Companies: 10,795·Total market cap: $144.5T
Global Bio-chem Technology Group Company Limited

Global Bio-chem Technology Group Company Limited

GBCMYOTCConsumer Defensive● Active
$0.41
+$0.00(+0.00%)
Market Cap$73875900
P/E Ratio
52W High$0.4873
52W Low$0.3226

Global Bio-chem Technology Group Company Limited (GBCMY) Revenue

Annual & quarterly revenue history · segment & region breakdown

GBCMY · revenue · updated Jun 9, 2026

Core revenue metrics

Global Bio-chem Technology Group Company Limited trailing twelve-month (TTM) revenue is $4.28B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$4.28B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
0.02×
mktCap ÷ TTM rev
Revenue per day
$12M
Est. TTM ÷ 365
Revenue / employee
$2730K
1567 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Global Bio-chem Technology Group Company Limited SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
GBCMY revenue by year · GBCMY revenue history · GBCMY annual revenue data

Compare revenue vs peers

Packaged Foods

Compare GBCMY revenue against listed peers. Click any row to open that company's revenue tab.

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Global Bio-chem Technology Group Company Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Global Bio-chem Technology Group Company Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Global Bio-chem Technology Group Company Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

GBCMY revenue · 4 questions

GBCMY's trailing twelve-month (TTM) revenue is $4.28B. That is an increase of 0.00% year-over-year from — in FY.

GBCMY revenueGBCMY annual revenuewhat is GBCMY revenueGBCMY TTM revenue

Source: FMP · Global Bio-chem Technology Group Company Limited SEC filings · GAAP · Global Bio-chem Technology Group Company Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026